Skip to main content
. 2019 Sep 11;12:445. doi: 10.1186/s13071-019-3702-6

Table 4.

Clinic location and number and percentage of dogs enrolled in a clinical field study investigating the efficacy and safety of combination chewable tablets administered orally once a month for 11 months for the prevention of heartworm disease in client-owned dogs presented in the USA

Clinic location Moxidectin/Sarolaner/Pyrantel combination product Heartgard® Plus Total
n % n % n %
Lake Worth, FL 12 4.4 6 4.3 18 4.4
West Palm Beach, FL 8 2.9 4 2.9 12 2.9
Boca Raton, FL 8 2.9 4 2.9 12 2.9
Bogart, GA 14 5.1 7 5.1 21 5.1
Baton Rouge 1, LA 9 3.3 4 2.9 13 3.2
Baton Rouge 2, LA 8 2.9 4 2.9 12 2.9
Livonia, LA 13 4.8 6 4.3 19 4.6
Metairie, LA 10 3.7 5 3.6 15 3.7
Zachary, LA 10 3.7 5 3.6 15 3.7
Wichita Falls, TX 8 2.9 4 2.9 12 2.9
Grapevine, TX 10 3.7 5 3.6 15 3.7
Lawrence, KS 8 2.9 4 2.9 12 2.9
Bartlesville, OK 20 7.4 10 7.2 30 7.3
Fort Collins, CO 10 3.7 5 3.6 15 3.7
Terre Haute, IN 11 4.0 6 4.3 17 4.1
Farragut, TN 10 3.7 6 4.3 16 3.9
Raleigh, NC 12 4.4 6 4.3 18 4.4
Springfield, MO 26 9.6 14 10.1 40 9.8
Quakertown, PA 23 8.5 12 8.7 35 8.5
Chester, CT 10 3.7 5 3.6 15 3.7
Caledonia, MI 12 4.4 6 4.3 18 4.4
Grand Rapids 1, MI 10 3.7 5 3.6 15 3.7
Grand Rapids 2, MI 10 3.7 5 3.6 15 3.7
Total 272 100 138 100 410 100